David Stolick Net Worth & Insider Trades
David Stolick - Chief Financial Officer, Brainstorm Cell Therapeutics Inc
What is David Stolick's Net Worth?
The current estimated net worth of Brainstorm Cell Therapeutics Inc's Chief Financial Officer, David Stolick, is estimated to be about $430.5K . David Stolick owns about 150,000 units of Brainstorm Cell Therapeutics Inc common stock. In the last 5 years at Brainstorm Cell Therapeutics Inc, David Stolick has sold an estimated value of $90K worth.
What is David Stolick's Past Insider Trading?
David Stolick's largest sale order was 150,000 units , worth over $54K on February 19, 2010. In total, David Stolick has made about 7 transactions over 5 years of their time at Brainstorm Cell Therapeutics Inc. David Stolick usually trades in February, with the busiest year in 2010 and 2006. The most recent transaction was a sale order of 100,000 units , worth over $36K on February 23, 2010.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
David Stolick
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is David Stolick's' Mailing Address?
- Mailing address is Gohen Is Retach Tikva L3 00000 Israel
What are Brainstorm Cell Therapeutics Inc's Past Insider Trades?
Brainstorm Cell Therapeutics Inc's most recent insider trade came on September 5, 2023 by Stacy Lindborg who bought 11,500 units worth $20.4K . In the last 19 years, insiders at Brainstorm Cell Therapeutics Inc have sold an estimated value of $2.07M and bought an estimated value of $6.21M worth of shares. Insider trading is most common in August, with the busiest year in 2011. The most active traders at the company are Irit Arbel, Director, Malcolm Taub, Director, and Robert Shorr, Director .
BRAINSTORM CELL THERAPEUTICS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |